D. Sobotta et al., Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype, J GEN VIROL, 81, 2000, pp. 369-378
Twelve MAbs were generated by immunization of BALB/c mice with plasma-deriv
ed hepatitis B virus surface spherical antigen particles subtype ayw2 (HBsA
g/ayw2 genotype D). Their epitopes were mapped by analysis of reactivity wi
th plasma-derived HBsAg/ayw2 and HBsAg/adw2 (genotype A) in enzyme immunoas
says and blots. Mapping was supported by nested sets of truncated preS2 pro
teins and preS2 peptides. Five antibodies were S domain-specific, seven wer
e preS2-specific and 11 had a preference for genotype D. According to our d
ata, group I of the three known epitope groups of preS2 has to be divided i
nto IA and IB. Three preS2-specific MAbs forming the new group IA reacted w
ith genotype D residues 3-15 which have not yet been described as an epitop
e region. IA antibodies strongly inhibited the binding of polymerized human
serum albumin. Two antibodies (group II) reacted with the glycosylated N-t
erminal region of preS2 in plasma-derived HBsAg, but not with a preparation
from transfected murine cells. One group III antibody was subtype-specific
and reacted with the highly variable preS2 sequence 38-48. Only one antibo
dy (group IB) mapped to the region (old group I) which was believed to be i
mmunodominant and genotype-independent. Geno(sub)type-specific epitopes of
preS2 are obviously the immunodominant components of natural HBsAg in BALB/
c mice, but these epitopes may be masked by serum albumins in humans. The d
ata may explain why it is difficult to detect anti-preS2 antibodies in huma
n recipients of preS2-containing vaccines, in spite of the preS2 immunodomi
nance in mice.